Bridgewater Associates’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
Other funds holding CRI
RI
Bridgewater Associates's CRI Position: Q2 2026 in Review
Bridgewater Associates increased its Carter's (CRI) stake by 40% in Q2 2026, buying an estimated $953K and bringing the position to 87,541 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #550.
Bridgewater Associates first reported a position in CRI in Q2 2014 and has held it in 24 quarters since. The position peaked at $8.18M in Q2 2022. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.
- Bridgewater Associates held 87,541 shares of Carter's worth $3.6M as of Q2 2026.
- Bridgewater Associates bought 25,178 Carter's shares in Q2 2026, an estimated $953K.
- Carter's made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #550 holding.
- Bridgewater Associates first reported a position in Carter's in Q2 2014 and has held it in 24 quarters since.
- Bridgewater Associates's Carter's position peaked at $8.18M in Q2 2022.
- 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.